Our policy in the Medical Programs Department of the National Psoriasis Foundation (NPF) is to ensure balance, independence, objectivity, and scientific rigor in all our educational programs. Anyone presenting or participating in the planning of any NPF CME programs is expected to disclose to the Medical Programs Department any real or apparent affiliation(s) within the past 12 months that may have a direct bearing on the subject matter of the continuing medical education program. The intent of this policy is to ensure continuing medical education programs that are free of commercial interests.
Mark Lebwohl, MD
Mark Lebwohl is an employee of the Mount Sinai Medical Center which receives research funds from AbbVie, Amgen, Boehringer Ingleheim, Celgene, Eli Lilly, Janssen Research & Development, LLC, Kadmon, LEO Pharma, Novartis, Pfizer, and ViDac.
Planning Committee: Susan Hardin has disclosed no relevant financial interests with any commercial interests.